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~ Antimicrobial susceptibilities of anaerobic bacteria isolated from 
the sputum of Cystic Fibrosis patients 
T.R. Field 1 , J.S. Elborn 2, M.M. Tunney 1 . 1 Clinical and Practice Research Group, 
School of Pharmacy, 2Respiratory Medicine Research Group, Queen ~' University 
Belfast, Belfast, BT9 7BL, UK 
Pulmonary infection, often with P aeruginosa, is the leading cause of  morbidity and 
mortality in patients with Cystic Fibrosis (CF). Recent evidence has suggested that 
areas within the CF lung are anoxic and we have shown that anaerobic bacteria are 
present in significant numbers in 80% of the sputum samples that we have examined. 
The antibiotics typically used to treat CF pulmonary infections demonstrate good 
activity against aerobes but are not routinely used in the treatment of anaerobic 
infections. We examined the susceptibility of anaerobes isolated from the sputum 
of  CF patients to antibiotics routinely used to treat CF pulmonary infection (cef- 
tazidime, meropenem, tobramycin and piperacillin/tazobactam) and to antibiotics 
routinely used to treat anaerobic infection (metronidazole and clindamycin). The 
susceptibility (minimal inhibitory concentration; MIC) of the anaerobic isolated to SASCV 
these antibiotics was determined by the agar dilution method according to NCCLS 
guidelines. Although there are no NCCLS breakpoints for interpreting MIC's for 
anaerobes to tobramycin, the concentration of  tobramycin required to inhibit the SA 
growth of the majority of the isolates was higher than that achievable clinically 
following IV administration. Surprisingly the majority of the anaerobes tested 
demonstrated resistance to metronidazole but were sensitive to clindamycin and Table 2 
piperacillin/tazobactam. These results suggest hat alternative antibiotic treatment 
regimes may be necessary to treat CF pulmonary infection i f  anaerobes are present. 
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~ Comparative activity of linezolid, quinupristin/dalfopristin and 
vancomycin against biofilm produced by cystic fibrosis (CF) 
isolates of Staphylococcus aureus (SA) normal and small colony 
variant (SCV) phenotypes 
P. Morelli, M. Mentasfi, G. Mamlo. G Gaslini Institute, Genova, Italy 
Ahns: Determine antibiotic susceptibility patlem, entity of biofilm (B) and tile efficacy of line- 
zolid (L), quinupristff~/dalfoprisNl (QD) and vancomycffl (V) to fflhibit and disrupt B of SA and 
SASCV colonising CF pts. 
Methods: 36 non repetitive SA (15 normal/21 SCV) were tested for MICs determination fplanktotfic 
cells by E-test and for B production, fflhibition and disruption in microfitre plates measured at 595 i~l 
after crystal violet staining. Results of B tests were classified in 3 categories (Stepanovic S. et al, 
1999). Antibiotic concentration used ranged from 0.125 to 1 l/g/nil for inhibition test and from 2 to 
16 big/nil for disruption test. 
Results: Antibiotic activities on plai~ctmfic cell and on B inhibition and disruption are shown in 
Table 1 and 2. Normal SA B formation revealed 60% low, 13% mid and 27% high producers, while 
SASCV B formation revealed 38% low, 33% mid and 28% high producers. 
Table 1 
MIC50 , gg/ml MIC90 , gg/ml MIC t~nge, gg/ml % S strains 
L 2 12 1 24 93 
QD 0.50 1.5 0.1~2 100 
V 1.5 1.5 0.75 2 100 
L 1.5 2 0.5 48 86 
QD 0.50 0.75 0.25 1 100 
V 1.5 1.5 1 2 100 
Inhibition (%) Disruption (%) 
SASCV L 39.0 55.4 65.0 86.5 46.3 49.0 58.0 62.0 
QD 88.2 96.7 99.8 99.9 42.0 47.0 53.2 61.8 
V 40.4 55.0 73.8 99.9 32.0 43.3 52.2 57.7 
SA L 16.0 30.4 49.7 70.0 8.0 16.0 23.0 42.6 
QD 97.0 97.8 99.8 99.9 10.0 10.5 25.4 33.3 
V 95.0 97.8 99.7 99.9 7.0 7.7 21.1 32.8 
• Investigating the antibiotic susceptibilities of the Burkholderia 
cepacia complex (Bcc) 
E. Caraher 1'2, G. Reynolds 1, R Murphy 3, S. McClean 1'2, M. Callaghan 1'2. 
l ITT-Dublin, 2National Institute for Cellular Biotechnology, 3AMNCH, Tallaght, 
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Burkholderia cepacia complex (Bcc) are associated with increased morbidity and 
mortality in patients with Cystic Fibrosis (CF). An important aspect of  Bcc lung 
infections is the ability of these organisms to form biofilms. A significant conse- 
quence of biofilm formation with clinical implications is the markedly enhanced 
resistance to antibiotics. The aim of this study was to determine the susceptibility 
of  Bcc strains grown planktonically and as a biofilm, to antibiotics currently in use 
to treat CF lung infections. 
Six Bcc strains representative ofB. multiuorans, B. cenocepacia and B. dolosa were 
employed in this study. The activity of nine antibiotics was assessed by conventional 
techniques (MIC). In vitro Bcc biofilms were cultured using a modification of the 
biofilm susceptibility assay (BIC) as previously described [1]. 
Overall the results demonstrate distinct differences between standard susceptibility 
testing (MIC) and testing performed with biofilm-grown Bcc with all strains 
showing marked resistance to meropenem and piperacillin-tazobactam when grown 
as a biofilm. Interestingly, aminoglycosides were effective against all the Bcc strains 
tested regardless of mode of growth. However, the increased resistance of Bcc 
strains to the majority of antibiotics when tested on biofilms may explain, at 
least in part, the poor clinical response of Bcc colonised CF patients to antibiotic 
therapy. Therefore the biofilm susceptibility assay may be a more suitable method 
for determining Bcc antibiotic susceptibility in a clinical environment and lead to 
improvements in antibiotic therapy for these patients. 
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Conclusions: In our series, SASCV isolates howed higher B production compared to SA. For B 
inhibition test, QD and V showed a betier activity on SA than on SASCV, while L was more active 
on SASCV. 
3 SA and 1 SCV were non sensitive to L. 
~ Characterization of Pseudomonas aeruginosa populations in 
sputum from CF lungs using FISH, various staining methods and 
confocal microscopy 
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Pseudomonas eruginosa is an opportunistic pathogen frequently causing chronic 
bacterial infections in the lungs of  patients with cystic fibrosis, CE From 6 such 
patients we have obtained frequent expectorate sputum samples, which have been 
analyzed for the presence and organization o fP  aeruginosa and other bacteria using 
Fluorescence In Situ Hybrization, FISH. Comparison of a large number of such 
confocal images from each of  the 6 patients showed that individual reproducible 
structural patterns could be observed in these samples. The FISH images also 
documented that biofilm-like aggregates found in some (but not all) of  the patients 
were composed of more than one type of bacteria. Antibiotic tolerance of the sputum 
populations o fP  aeruginosa was investigated by in situ live-dead staining combined 
with viability assessments by plating. The presence of  mucoid cells was investigated 
by staining with calcofluor white in combination with FISH and by plate spreading 
and inspections. These methods were used to monitor the effect of intensive 
antibiotic therapy on the patients during hospitalization, and it was found that 
although the treatment clearly reduced the density of the bacterial population in the 
sputa, the antibiotics ome times had differential effects on various subpopulations 
o fP  aeruginosa. In essence, it was found that antibiotics were surprisingly effective 
in eliminating some of the chronically infecting pseudomonads, but after the end 
of the treatment period the very same subpopulation re-appeared establishing again 
a balance of biodiversity. 
